Yibeile®, the strategic core brand under Huadong Medicine (Stock Code: 000963) subsidiary Nannong Animal Pharmaceutical, specializes in innovative medical solutions within the therapeutic pharmaceuticals sector for pets. Centered on anesthesia, analgesia, and sedation, we integrate cutting-edge technologies and pioneering research to deliver precise, safe, and highly effective treatment protocols for companion animals.
Through sustained scientific innovation, we are building an integrated healthcare ecosystem spanning from pain management to full-lifecycle health management. Committed to leading the advancement of the veterinary medicine industry, we thereby empower every pet to access higher-quality medical care.